DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy Designation Potential to be the first FDA-approved therapeutic...
Month: August 2025
NEWYou can now listen to Fox News articles! Police in Cincinnati are investigating a viral video that shows what appears...
